FIELD: gynecology. SUBSTANCE: invention relates to substitutional hormone therapy in women in climacteric period and menopause. In particular, woman receives estrogen combined with antiprogestin in dose effective to suppress estrogen-caused endometrium accrementation and create amenorrhea. EFFECT: avoided undesired uterine bleeding. 20 cl, 1 dwg, 2 tbl, 9 ex
Authors
Dates
1999-10-10—Published
1994-02-18—Filed